Résumé
Le nombre de plus en plus grand des travaux consacrés chaque année à l'étude de la douleur, attestent que ce domaine de recherche est plus que jamais d'actualité. Cette revue vise à résumer, sans prétendre à l'exhaustivité, les résultats de travaux récents concernant les aspects fondamentaux, cliniques et thérapeutiques de la douleur, qui nous semblent constituer des avancées significatives.
Summary
The number of works devoted to pain is increasing every year, showing the major interest for pain in the scientific community. In this review are summarized some recent data that, in our opinion, have significantly contributed to our understanding of the basic, clinical and therapeutical aspects of pain.
Bibliographie
Talbot J.D., Marrett S., Evans A.C., Meyer E., Bushnell M.C. and Duncan G.H.: Multiple representations of pain in human cerebral cortex. Science 251, 1355–1358, 1991.
Casey K.L., Minoshima S., Berger K.L., Koeppe R.A., Morrow T.J. and Frey K.A.: Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J. Neurophysiol. 71, 802–807, 1994.
Coghill R.C., Talbot J.D., Evans A.C., Meyer E., Gjedde A., Bushnell M.C. and Duncan G.H.: Distributed processing of pain and vibration by the human brain. J. Neuroscience 14, 4095–4108, 1994.
Jones A.K.P., Friston K.J. and Frackowiack R.S.J.: Cerebral localisations of responses to pain in man using positron emission tomography. Science 255, 215–216, 1992.
Hsieh J.C., Belfrage M., Stone-Elander S., Hansson P. and Ingvar M.: Central representation of chronic pain studied by positron emission tomography. Pain 63, 225–236, 1995.
Iadarola M.J., Max M.B., Berman K.F., Byas-Smith M.G., Coghill R.C., Gracely R.H. and Bennett G.J.: Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 63, 55–64, 1995.
Kakigi R., Koyama S., Hoshiyama M., Kitamura Y., Shimojo M. and Watanabe S.: Pain-related magnetic fields following painful CO2 laser stimulation in man. Neurosci. Lett. 192, 45–48, 1995.
Giesler G.J., Katter J.T. and Dado R.J.: Direct spinal pathways to the limbic system for nociceptive information. Trends in Neurosci. 17, 244–250, 1994.
Villanueva L, Bouhassira D. and Le Bars D.: The medullary subnucleus reticularis dosalis (SRD) as a key link in both the transmission and modulation of pain signals. Pain (in press), 1996.
Bernard J.F. and Besson J.M.: The spino(trigemino)-pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J. Neurophysiol. 63, 473–490, 1990.
Bernard J.F., Huang G.F. and Besson J.M.: The parabrachial area: electrophysiological evidence for an involvement in visceral nociceptive processes. J. Neurophysiol. 71, 1646–1660, 1994.
Dubner R.: Neuronal plasticity and pain following poripheral tissue inflammation or nerve injury. In: Bond M.R., Charlton J.E., Woolf C.J. (eds), Proceedings of the Vith World Congress on Pain, Elsevier: Amsterdam, pp. 264–276, 1991.
Price D.D., Mao J. and Mayer D.: Central mechansm of normal and abnormal pain states. In: Fields H.L., Liebeskind J.C. (eds), Progress in Pain Research and Management vol. 1, IASP Press: Seattle, pp. 61–84, 1994.
Wilcox G.L.: Excitatory neurotransmitters and pain. In: Bond M.R., Chariton J.E., Woolt C.J. (eds), Proceedings of the Vith World Congress on Pain, Elsevier: Amsterdam, pp. 97–117, 1991.
Coderre T.J., Katz J., Vaccarino A.L. and Melzack: Contribution of central neuroplasticity to pathological pain: review of clinical and expermental evidence. Pain 52, 259–285, 1993.
Sugimoto T., Bennett G.J. and Kajander K.C.: Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection and strychnine. Pain 42, 205–213, 1990.
Woolf C.J., Shortland P. and Coggeshall R.E.: Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355, 75–78, 1992.
Shortland P. and Woolf C.J.: Chronic peripheral nerve section results in a rearrangement of the central axonal arborizations of axotomized A beta primary afferent neurons in the rat spinal cord. J. Comp. Neurol. 330, 65–82, 1993.
Koerber H.R., Mirnics K., Brown P.B. and Mendell L.M.: Central sprouting and functional plasticity of regenerated primary afferents. J. Neurosci. 14, 3655–3671, 1994.
Flor H., Elbert T., Knecht S., Wienbruch C., Pantov C., Birbaumer N., Larbig and Taub E.: Phantom-limb pain as a perceptual correlate of cortical reorganization follwing arm amputation. Nature 375, 482–484, 1995.
Ferreira S. and Nakamura M.: Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antsgonists. Prostaglandin 23, 53–60, 1979.
Stein C., milan M., Shippenberg T. et al.: Periphral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta, kappa receptors. J. Pharmacol. Exp. Ther. 248, 1269–1275, 1989.
Stein C., Comisel K., Hairmerl E. et al.: Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N. Engl. J. Med. 325, 1123–1126, 1991.
Hargreaves K.M., Keating K., Cathers S. and Dionne R.: Analgesic effect of morphine after PDL injection in ondodotic pationts. J. Dent. Res. 70, 445, 1990.
Vane J.R.: Towards a better aspirin. Nature 367, 215–216, 1994.
Shyu K.W. and Lin M.T.: Hypothalamic monoaminorgie mechanism of aspirin induced analgesia in monkeys. J. Neural Transmission 62, 285–293, 1985.
Meglio M., Cioni B., Moles A., Puca A. and Visocchi M.: Antinociceptive activity of intracebroventricular lysine acetylsalicilate: an experimental study. Acta Neurochirurgica 52 (suppl): 5–6, 1991.
Tjolsen A., Lund A. and Hole K.: Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic system. Eur. J. Pharmaccl. 193, 193–201, 1991.
Pélissier T., Alloui A., Caussade F., Cloarec A., Lavarenne J. and Eschalier A.: Evidence for a spinal trosipetron-inhibited antinociceptive effect of paracetamol. Fundam. Clin. Pharmacol. 8, 263, 1994.
Malmberg A.B. and Yasksh T.L.: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by cyclooxygenase inhibition. Science 257, 1276–1279, 1992.
Jurna I. and Brune K.: Central effect of the non-steroid anti-inflammatory agents, indometacin, ibuprofen, and diclofenac, determined in C-fibre activity in single neurones of the rat thalamus. Pain 41, 71–80, 1990.
Bustamante D., Paeile C., Willer J.C. and Le Bars D.: Effects of intraveinous nonsteroidal antiinflammatory drugs on a C-Fiber reflex elicited by a wide range of stimulus intensities in the rat. J. Pharmacol. Exp. Ther. 276, 1232–1243, 1996.
Willer J.C., De Broucker T., Bussel B., Roby-Bramy A. and Harrewyn J.M.: Central analgesic effects of ketoprofen in humans: electrophysiological evidence for a supraspinal mechanism in a double-blind crossover study. pain 38, 1–7, 1989.
Frushstorfer H., Lindblom U. and Schmidt W.G.: Method for quantitative estimation of thermal thresholds in patients. J. Neurol. Neurosurg. Psychiatry 39, 1071–1075, 1976.
Fisher A.A.: Pressure algometry over normal muscles. Standard value, validity and reproducibility of pressure threshold. Pain 30, 115–126, 1987.
Hansson P. and Lindblom U.: Hyperalgesia assessed with quantitative sensory testing in patients with nourogenic pain. In: Willis W.D. (ed.), Hyperalgesia and Allodynia. New York: Raven Press, Ltd., pp. 335–343, 1992.
Merskey H.: Classification of chronic pain-Descriptions of chronic pain syndromes and definition for terms. Prepared by IASP Sub-Committee on taxonomy. Pain (suppl) 3, 216–225, 1986.
Blumberg H.A.: A new clinical approach for diagnosing reflex sympathetic dystrophy. In: Bond M.R. et al. (eds.), Pain ressarch and clinical management, Vol. 4, Elsevier, Amsterdam, pp. 399–403, 1991.
Roberts W.J.: A hypothesis on the physiological basis for causalgia and related pains. Pain 24, 297–311, 1986.
Stanton-Hicks, janig W., Hassenbusch S., Hadock J.D., Boas R. and Wilson P.: Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 63, 127–133, 1995.
Ochoa J.L.: The newly recognized painful ABC syndrome: thermographic aspects. Thermology 2, 65–107, 1986.
Ochoa J.L. and Yarnitsky D.: The triple cold syndrome. Cold hyperalgesia, cold hypoesthesia and cold skin in peripheral nerve disease. Brain 117, 185–197, 1994.
Stewart W.F., Lipton R., Celentano D.D. and Reed M.L.: Prevalence of migraine headache in the United States. JAMA 267, 64–69, 1992.
Rasmussen B.K., Jensen R., Schroll M. and Olesen J.: Epidemiology of headache in a general population. A prevalence study. J. Clin. Epidemiol. 44, 1147–1157, 1991.
Edmeads J., Findlay H., Tugwell P., Pryse-Philips W., Nelson R.F. and Murray T.J.: Impact of migraine and tension-type headache on life-style, consulting behaviour and medication use: a canadian population survey. Can. J. Neurol. Sci. 20, 131–137, 1993.
Henry P., Michel P., Brochet B. et al. A nationwide survey of migraine in France: Prevalence and clinical features in adults. Cephalalgia 12, 229–237, 1992.
Rasmussen B.K., Jensen R. and Olesen J.: Impact of headache on sickness absence and utilisation of medical services. A Danish population study. J. Epidemiol. Comm. Health 46, 443–446, 1992.
Max M.B., Schaffer S.C., Culnane M., Dubner R. and Gracely R.H.: Association of pain relief with drug side effects in post-herpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo. Clin. Pharmacol. Ther. 43 363–371, 1988.
Arner S. and Meyerson B.: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11–23, 1988.
Portenoy R.K., Foley K.M. and Inturisi E.: The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43, 273–286, 1990.
Portenoy R.K.: Chronic opioid therapy in nonmalignant pain. J. Pain Symptom. Manage. 5, 46–62, 1990.
Rowbotham M.C., Reisner-Keller L.A. and Fields H.L.: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41, 1024–1028, 1991.
Jadad A.R., Carroll D., Glynn C.J., Moore R.A. and McQuay H.J.: Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient controlled analgesia. Lancet 329, 1367–1371, 1992.
Kupars R.C., Konings H., Adrienson H. and Gybels J.M.: Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 47, 4–12, 1991.
Backonja M., Arndt G., Gombar K.A., Check B. and Zimmermann M.: Responses of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 56, 51–57, 1994.
Eide P.K., Jorum E., Stubhaub A., Bremmes J. and Breivik. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 58, 347–354, 1994.
Eide P.K., Strubhaug A., Oye I. and Breivik H.: Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 61, 221–228, 1995.
Kristensen J.D., Svensson B. and Gordh T.: The NMDA-receptor antagonist CCP abolishes neurogenic «wind-up» pain after intrathecal administration in humans. Pain 51, 249–253, 1992.
Wall P.D.: The prevention of postoperative pain. Pain 33, 289–290, 1988.
McQuay H.J.: Pre-amptive analgesia: a systematic review of clinical studies. Ann. Med. 27, 249–256, 1995.
Flath R.K., Hicks M.I., Dionne R.A. and Pelleu G.B.: Pain suppression after pulpectomy with preoperative flurbiprofen. J. Endod. 13, 339–347, 1987.
Sisk A.L., Mosley R.O. and Martin R.P.: Comparison of preoperative and postoperative diflunisal for supression of postoperative pain. J. Oral. Maxillofac. Surg. 47, 464–468, 1989.
Sisk A.L. and Grover B.J.: A comparison of preoperative and postoperative naproxen sodium for suppression of postoperative pain. J. Oral. Maxillofac. Surg. 48, 674–678, 1990.
Gustafsson I., Nystrom E. and Quilding H.: Effect of preoperative paracetamol on pain after oral surgery. Eur. J. Clin. Pharmacol. 24, 63–65, 1983.
Ejlersen E., Andersen H.B., Eliasen K. and Mogensen T.: A comparison between preincisional and postincisional lidocaine infiltration and postoperative pain. Anesth. Analg. 74, 495–498, 1992.
Turner G.A. and Chalkiadis G.: Comparison of preoperative with postoperative lignocaine infiltration on postoperative analgesia requirements. Br. J. Anesth. 72, 541–543, 1994.
Katz J., Kavanagh B.P., Sandler A.N. et al.: Preemptive analgesia. Clinical evidence of neuroplasticity contributing to postoparative pain. Anesthesiology 77, 439–446, 1992.
Richmond C.E., Bromley L.M. and Woolf C.J.: Preoporative morphine pre-ompts postoperative pain. Lancet 342, 73–75, 1993.
Richmond C.E., Bromley L.M. and Woolf C.J.: Preoporative morphine pre-empts postoperative pain. Lancet 342, 73–75, 1993.
Wilson R.J.T., Loith S., Jackson I.J.B. and Hunter D.: Pre-emptive analgesia from intraveinous administration of opioids. Anesthesia 49, 591–593, 1994.
Jannetta P.J.: Neurovascular compression in cranial nerve and systemic disease. Ann. Surg. 192, 518–525, 1980.
Apfelbaum R.I.: A comparison of percutaneous radiofrequency trigeminal neurolysis and microvascular decompression of the trigeminal nerve for the treatment of tic douloureux. Neurosurgery 47, 16–21, 1977.
Bederson J.B. and Wilson C.B.: Evaluation of microvascular decompression and partial sensory rhizotomy in 252 cases of trigeminal neuralgia. J. Neurosurg. 71, 359–367, 1987.
Sindou M., Keravel Y., Abdennedi B. et Szapiro J.: Traitement neurochirurgical de la névralgie trigéminale: abord direct ou méthode percutanée? Neurochirurgie 33, 89–111, 1987.
Wilson C.B., Yorke C. and Prioleau G.: Microsurgical vascular decompression for trigeminal neuraigia and hemifacial spasm. West J. Med. 132, 481–484, 1980.
Burchiel K.J., Clarke H., Haglund M. and Looser J.D.: Long-term efficacy of microvascular decompression in trigeminal neuralgia. J. Neurosurg. 69, 35–38, 1988.
Fukushima T.: Microvasular decompression for hemifacial spasm and trigeminal neuralgia: results in 4000 cases. J. Neurol. Neurosurg. Psychiatry 53, 811, 1990.
Van Loveren H., Tew J.M., Keller J.T. and Nurre M.A.: A 10-year experience in the treatment of trigeminal neuralgia. J. Neurosurg. 57, 757–764, 1982.
Adams C.B.T.: Microvascular compression: an alternative view and hypothesis. J. Neurosurg. 57, 1–12, 1989.
Rueff A. and Dray A.: 5-Hydroxytryptamine-induced sensitization and activation of peripheral fibre in the neonatal rat are mediated via different 5-Hydroxytryptamine receptors. Neurosci. 50, 899–905, 1992.
Herbert M.K. and Schmidtt R.F.: Activation of normal and inflamed fine articular units by serotonin. Pain 50, 79–88, 1992.
Moskowitz M.A. and Cutrer F.M.: Possible importance of neurogenic inflammation within the meninges to migraine headeches. In: Progress in Pain Research and Management, Vol. 1, Fields H.L. and Liebeskind J.C., IASP Press, pp. 43–49, 1994.
Peroutka S.J.: Hydroxytryptamine receptors. J. of Neurechem. 60, 408–416, 1993.
Humphrey P.P.A., Feniuk W., Marriot A.S. et al.: Pre-clinical studies on the antimigraine drug sumatriptan. Eur. Neurol. 31, 282–290, 1991.
Moskowitz M.A.: Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends in Pharmacol. Sci. 13, 307–311, 1992.
Buzzi M.G. and Moskowitz M.A.: The antimigraine drug, sumatriptan (GR43175), specifically blocks neurogenic plasma extravasation from bood vessels in dura mater. Br. J. Pharmacol. 99, 202–206, 1990.
Plosker G.L. and McTravish D.: Sumatriptan: A resppraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 47, 622–651, 1994.
Tansey M.J.B., Pilgrim A.J. and Lloyd K.: Sumatriptan in the acute treatment of migraine. J. Neurol. Sci. 114, 109–116, 1993.
Visser W.H., Klein K.B., Cox R., Marks S.J. and Ferrari M.D.: 311C90, a new central and peripherally acting 5HT1D receptor agonist in the acute oral treatment of migraine: a double blind, placebo controlled dose-range finding study. Neurology 46, 522–526, 1996.
Jadad A.R., Caroll D., Glynn C.J. and Mc Quay H.J.: Intraveinous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized double-blind crossover study. J. Pain Symptom. Manage. 10, 13–20, 1995.
Arner S.: Intravenous phentolamine test: diagnostic and prognostic use in reflex sympathetic dystrophy. Pain 46, 17–22, 1991.
Dellomijn P.L., Fields H.L., Allen R.R., McKay W.R. and Rowbotham M.C.. The interpretation of pain relief and sensory changes following sympathetic blockade. Brain 117, 1475–1487, 1994.
Raja S.N., Treede R.D., Davis K.D. and Camphell J.N.: Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain. Anesthesiol. 74, 691–698, 1991.
Verdugo R. and Ochoa J.L.: «Sympathetically maintained pain» l. Phentolamine block questions the concept. Neurology 44, 1003–1010, 1994.
Ramamurthy S. and Hoffman J.: Intraveinous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: A randomized, double-blind study. Anesth. Analg. 81, 718–723, 1995.
Author information
Authors and Affiliations
About this article
Cite this article
Bouhassire, D., Attal, N. Actualités de la douleur le point de vue de deux neurologues. Doul. et Analg. 9, 73–86 (1996). https://doi.org/10.1007/BF03003130
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03003130